Discussion forum for Pharma Quality events, Regulatory Actions
FDA Announce Decision to Withdraw Approval of Makena (hydroxyprogesterone caproate injection) a drug approved to reduce the risk of preterm birth in women pregnant with one baby who have a history of spontaneous preterm birth Read More..
Leave a Comment
You must be logged in to post a comment.